Antara Capital LP Clovis Oncology, Inc. Put Options Transaction History

Antara Capital LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $1.89 Million - $8.88 Million	3,000,000 New	3,000,000 $5.4 Million
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $1.38 Million - $2.43 Million	-510,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.06 - $5.8 $6.05 Million - $8.64 Million	-1,490,000 Reduced 74.5%	510,000 $2.28 Million
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $10 Million - $14.1 Million	2,000,000 New	2,000,000 $11.6 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.